Anaphylactoid hypersensitivity reaction from intra-arterial cetuximab: Clinical considerations and management

Intra-arterial infusion of drugs shows promising results in terms of safety and efficacy. Intra-arterial cetuximab, a monoclonal antibody treatment, is currently being tested for its use in head and neck cancers. We present the case of a 45-year-old Asian male who developed an anaphylactoid hypersen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardash, Yonatan, Tham, Tristan, Olson, Caitlin, Khaymovich, Julian, Costantino, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350015/
https://www.ncbi.nlm.nih.gov/pubmed/30728973
http://dx.doi.org/10.1177/2050313X18823447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350015/
https://www.ncbi.nlm.nih.gov/pubmed/30728973
http://dx.doi.org/10.1177/2050313X18823447

Ejemplares similares